| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |